185 related articles for article (PubMed ID: 15793132)
1. Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus.
Koort JK; Mäkinen TJ; Suokas E; Veiranto M; Jalava J; Knuuti J; Törmälä P; Aro HT
Antimicrob Agents Chemother; 2005 Apr; 49(4):1502-8. PubMed ID: 15793132
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of vancomycin-releasing biodegradable poly(lactide-co-glycolide) antibiotics beads for treatment of experimental bone infection due to Staphylococcus aureus.
Ueng SW; Lin SS; Wang IC; Yang CY; Cheng RC; Liu SJ; Chan EC; Lai CF; Yuan LJ; Chan SC
J Orthop Surg Res; 2016 Apr; 11(1):52. PubMed ID: 27121956
[TBL] [Abstract][Full Text] [Related]
3. Comparative 18F-FDG PET of experimental Staphylococcus aureus osteomyelitis and normal bone healing.
Koort JK; Mäkinen TJ; Knuuti J; Jalava J; Aro HT
J Nucl Med; 2004 Aug; 45(8):1406-11. PubMed ID: 15299068
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler.
Mäkinen TJ; Veiranto M; Lankinen P; Moritz N; Jalava J; Törmälä P; Aro HT
J Antimicrob Chemother; 2005 Dec; 56(6):1063-8. PubMed ID: 16234335
[TBL] [Abstract][Full Text] [Related]
5. 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan for monitoring the therapeutic response in experimental Staphylococcus aureus foreign-body osteomyelitis.
Chatziioannou S; Papamichos O; Gamaletsou MN; Georgakopoulos A; Kostomitsopoulos NG; Tseleni-Balafouta S; Papaparaskevas J; Walsh TJ; Pneumaticos SG; Sipsas NV
J Orthop Surg Res; 2015 Aug; 10():132. PubMed ID: 26306506
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres.
Yan L; Jiang DM; Cao ZD; Wu J; Wang X; Wang ZL; Li YJ; Yi YF
Drug Des Devel Ther; 2015; 9():3665-76. PubMed ID: 26213463
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 18F-FDG and 68Ga PET imaging in the assessment of experimental osteomyelitis due to Staphylococcus aureus.
Mäkinen TJ; Lankinen P; Pöyhönen T; Jalava J; Aro HT; Roivainen A
Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1259-68. PubMed ID: 16007423
[TBL] [Abstract][Full Text] [Related]
8. Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant.
Koort JK; Makinen TJ; Suokas E; Veiranto M; Jalava J; Tormala P; Aro HT
Acta Orthop; 2008 Apr; 79(2):295-301. PubMed ID: 18484258
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic-loaded biodegradable bone cement for prophylaxis and treatment of experimental osteomyelitis in rats.
Gerhart TN; Roux RD; Hanff PA; Horowitz GL; Renshaw AA; Hayes WC
J Orthop Res; 1993 Mar; 11(2):250-5. PubMed ID: 8483037
[TBL] [Abstract][Full Text] [Related]
10. Effective treatment of osteomyelitis with biodegradable microspheres in a rabbit model.
Ambrose CG; Clyburn TA; Louden K; Joseph J; Wright J; Gulati P; Gogola GR; Mikos AG
Clin Orthop Relat Res; 2004 Apr; (421):293-9. PubMed ID: 15123963
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of bioabsorbable antibiotic containing bone screw in the prevention of biomaterial-related infection due to Staphylococcus aureus.
Mäkinen TJ; Veiranto M; Knuuti J; Jalava J; Törmälä P; Aro HT
Bone; 2005 Feb; 36(2):292-9. PubMed ID: 15780955
[TBL] [Abstract][Full Text] [Related]
12. Comparable efficacies of the antimicrobial peptide human lactoferrin 1-11 and gentamicin in a chronic methicillin-resistant Staphylococcus aureus osteomyelitis model.
Faber C; Stallmann HP; Lyaruu DM; Joosten U; von Eiff C; van Nieuw Amerongen A; Wuisman PI
Antimicrob Agents Chemother; 2005 Jun; 49(6):2438-44. PubMed ID: 15917544
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin-laden calcium phosphate-calcium sulfate composite allows bone formation in a rat infection model.
Boyle KK; Sosa B; Osagie L; Turajane K; Bostrom MPG; Yang X
PLoS One; 2019; 14(9):e0222034. PubMed ID: 31536540
[TBL] [Abstract][Full Text] [Related]
14. PMMA is superior to hydroxyapatite for colony reduction in induced osteomyelitis.
Zelken J; Wanich T; Gardner M; Griffith M; Bostrom M
Clin Orthop Relat Res; 2007 Sep; 462():190-4. PubMed ID: 17514008
[TBL] [Abstract][Full Text] [Related]
15. Experimental osteomyelitis treatment with antibiotic-impregnated hydroxyapatite.
Shirtliff ME; Calhoun JH; Mader JT
Clin Orthop Relat Res; 2002 Aug; (401):239-47. PubMed ID: 12151901
[TBL] [Abstract][Full Text] [Related]
16. Examination of a novel, specified local antibiotic therapy through polymethylmethacrylate capsules in a rabbit osteomyelitis model.
Börzsei L; Mintál T; Koós Z; Kocsis B; Helyes Z; Kereskai L; Nyárády J
Chemotherapy; 2006; 52(2):73-9. PubMed ID: 16567940
[TBL] [Abstract][Full Text] [Related]
17. Treatment of osteomyelitis with a biodegradable antibiotic implant.
Calhoun JH; Mader JT
Clin Orthop Relat Res; 1997 Aug; (341):206-14. PubMed ID: 9269175
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable microspherical implants containing teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
Orhan Z; Cevher E; Yildiz A; Ahiskali R; Sensoy D; Mülazimoğlu L
Arch Orthop Trauma Surg; 2010 Jan; 130(1):135-42. PubMed ID: 19434413
[TBL] [Abstract][Full Text] [Related]
19. The longitudinal assessment of osteomyelitis development by molecular imaging in a rabbit model.
Odekerken JC; Walenkamp GH; Brans BT; Welting TJ; Arts JJ
Biomed Res Int; 2014; 2014():424652. PubMed ID: 25295260
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of ciprofloxacin implants in treating experimental osteomyelitis.
Alvarez H; Castro C; Moujir L; Perera A; Delgado A; Soriano I; Evora C; Sánchez E
J Biomed Mater Res B Appl Biomater; 2008 Apr; 85(1):93-104. PubMed ID: 17696153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
